By Maria Pearson As a technology teacher who had a long career with IBM before going into education, I have encountered all sorts of opportunities to teach – and to learn. The biggest such opportunity of my life occurred at the intersection of cancer, technology, and Dana-Farber. In August 2010, I was diagnosed with stage III multiple myeloma, a blood cancer. No search engine was adequate in comforting my fears of life expectancy, treatment, or facing a stark life-altering challenge.
By Judy Garber, MD, MPH We know that women who inherit harmful mutations in the genes BRCA1 or BRCA2 have a sharply increased risk of developing breast and/or ovarian cancer at an early age (prior to menopause). In fact, women with inherited BRCA1 or 2 mutations are about five times more likely to develop breast cancer – and at least 10 times more likely to develop ovarian cancer – than women without such mutations, according to the National Cancer Institute.
By Melissa Cochran, MS, NP For my cancer patients, a stem cell transplant is a life-changing event. They cannot work outside the home for a full year; visits to Dana-Farber are about the only excursions allowed. No more trips to the grocery store or dinners at a favorite restaurant. In our clinic, we have a solid team in place – physicians, nurses, social workers, and nurse practitioners like myself – working together to support and anticipate each cancer patient’s needs along the way. As you can imagine, significant physical and emotional issues can arise for our patients.
Pink may be the color for breast cancer advocacy, but that doesn’t mean men can’t be diagnosed with the disease. Each year, 2,000 men in the U.S. receive a breast cancer diagnosis. Current treatments are highly effective in men whose cancer is treated early. However, because men aren’t familiar with breast cancer symptoms, diagnosis is often delayed.
Not long ago, doctors were often skeptical when cancer patients who had undergone chemotherapy complained that they were mentally foggy; unable to plan a week’s worth of meals or organize their finances as they could before. Patients called this side effect “chemobrain” and were frustrated by the lack of recognition – or suggested remedies – from their physicians.
Bob Hurkett doesn’t know what became of the little girl he first heard of in 1998, but he thinks about her often. She was 5 years old and needed a bone marrow transplant. Hurkett and his wife, Jane, attended a donor drive hosted by the girl’s family where their blood was drawn and tested as a possible match. Neither was a match but Hurkett felt compelled to help. When he learned about the need for platelets – which are vitally important for cancer patients as a means of replacing their own depleted supplies, as well as for trauma victims and …
When Gov. Deval Patrick signed an oral chemotherapy parity bill into law on January 5, Massachusetts joined more than 20 states requiring health plans to cover oral cancer pills at a rate no less favorable than standard intravenous (IV) chemotherapy. The new law tells insurers that they cannot require higher patient costs for oral chemotherapy, and it helps ensure that all forms of chemotherapy are accessible and affordable to Massachusetts cancer patients.